Form 4: Merck & Co. Director Thomas H. Glocer Reports Acquisition of Phantom Stock Units
SEC Form 4 Filing
Director Thomas H. Glocer reports acquisition of phantom stock units and holdings in Merck & Co., Inc.
Summary
- Thomas H. Glocer, a director at Merck & Co., Inc., filed a Form 4 indicating changes in beneficial ownership.
- The report details the acquisition of 341.0383 phantom stock units on March 28, 2024, at a price of $131.95 per unit.
- These phantom stock units are to be settled in cash upon the director's termination of service, according to a pre-selected distribution schedule.
- The report also indicates that Glocer directly owns 5,100 shares of Merck & Co. common stock.
- Following the reported transactions, Glocer beneficially owns 93,360.3983 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company directors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the transactions of a company director.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of transaction involving phantom stock units. |
| 03/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.